39734711000001105: Co-careldopa 12.5mg/50mg tablets (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Co-careldopa 12.5mg/50mg tablets
\UK product\Virtual therapeutic moiety\Co-careldopa\Co-careldopa 12.5mg/50mg tablets

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Co-careldopa 12.5mg/50mg tablets
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Co-careldopa 12.5mg/50mg tablets
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing carbidopa and levodopa\Co-careldopa\Co-careldopa 12.5mg/50mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Co-careldopa 12.5mg/50mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing carbidopa and levodopa\Co-careldopa\Co-careldopa 12.5mg/50mg tablets
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Co-careldopa 12.5mg/50mg tablets
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing carbidopa and levodopa\Co-careldopa\Co-careldopa 12.5mg/50mg tablets

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1815691000001110 Co-careldopa 12.5mg/50mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1815701000001110 Co-careldopa 12.5mg/50mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Co-careldopa 12.5mg/50mg tablets	Is a	Co-careldopa	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	tablet.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Is a	Product containing carbidopa and levodopa	false	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Carbidopa	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has specific active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has specific active ingredient	Carbidopa monohydrate	true	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Plays role	Antiparkinson therapeutic role	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Co-careldopa 12.5mg/50mg tablets (Somex Pharma)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (DE Pharmaceuticals)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Alliance Healthcare (Distribution) Ltd)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets 90 tablet	Has VMP	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Zentiva Pharma UK Ltd)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Sinemet 12.5mg/50mg tablets (Organon Pharma (UK) Ltd)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (A A H Pharmaceuticals Ltd)	Is a	True	Co-careldopa 12.5mg/50mg tablets	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1815691000001110	Co-careldopa 12.5mg/50mg tablets	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1815701000001110	Co-careldopa 12.5mg/50mg tablets (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module